A corporation named Aethera, based in South Africa, holds the monopoly for a drug called AIRemedy, which they claim protects its users from the toxins, thus allowing them effective total control over humanity's fate.

Right afterwards, Ella collapses and, after awakening, begins to develop mutagenetic changes, including enhanced strength, gliding ability, and the manifestation of abnormal skin growths and retractable chitinous spurs.

Believing that Ella killed him, Gina calls the police on her, and the resulting manhunt attracts the attention of Eric O'Connors, the son of Aethera's chairman and head of the corp's research division.

However, as her mutation progresses, Ella gains enhanced auditory senses and overhears a discussion between O'Connors and his father in which they mention that she will likely not survive the extraction of the reagent from her genome.

Ella meets Lazarus, who is secretly O'Connors' personal aide Angela, and offers her cooperation in providing the world with the choice of an adaptive mutation for mankind's survival.

The concept for the film was in development for several years before being put to screen; production was originally scheduled to take place in 2019, but was postponed to be re-financed while Egan worked on her other sci-fi slate (starting with Glasshouse) in the meantime.

[1] The cast included Grace Van Dien, Daniel Sharman, Keenan Arrison, Tina Redman, Robyn Roussouw, Tafara Nyatsanza, Nicole Fortuin, Clancy Brown, and Caleb Payne.